ARGX

argenx SE

1ARGX
NLD
NASDAQ

$387.05

24H

0.33%

Market Cap

23 B

Volume

167.2 K

Supply

59.4 M

Price Chart

About argenx SE - ARGX

Argenx SE is a biotechnology company that specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. The company is known for its innovative ARGX-113 (efgartigimod) product, among others, which aims to modulate the immune system.

What are argenx SE's core values and mission statement?

Argenx SE's mission is to harness the power of the immune system to improve the lives of people suffering from cancer and severe autoimmune diseases. Their core values revolve around innovation, collaboration, and the commitment to developing life-changing therapies.

Who founded argenx SE and when?

argenx SE was founded by Tim Van Hauwermeiren, Hans de Haard, and Torsten Dreier in 2008.

Who leads argenx SE?

As of the last update, argenx SE was led by Tim Van Hauwermeiren, who serves as the Chief Executive Officer (CEO).

Where is argenx SE located, and what is its base country?

Argenx SE is headquartered in the Netherlands, which is its base country.

On which exchanges is argenx SE traded?

Argenx SE is traded on the NASDAQ under the ticker symbol ARGX and on the Euronext Brussels.

Historical data

1D
5D
1M
6M
1Y
MAX
Day
Open/Close
Low/High
Volume
Cap

argenx SE (ARGX) Price Live Data

The live price of argenx SE (ARGX) is $387.05, with a trading volume of 167,180 in the last 24 hours. Wrapstocks updates the ARGX price in real-time. argenx SE is down -0.33% in the last 24 hours. The company has a live market cap of $23,002,806,272.00 and a supply of 59,431,097 ARGX stocks.

argenx SE (ARGX) is traded on NASDAQ Stock Exchange, and currently, the market is open; trading will be paused in 5 hours and 25 minutes.

Exchange
NASDAQ
NASDAQ
NASDAQ Stock Exchange
USA
Closes in
5 hours and 25 minutes
Working Hours
Mon-Fri, 01:30 PM - 08:00 PM
Timezone
GMT+0
Last Updated
14 Jun 2024 07:56 PM